Mesenchymal stem cells derived from human pluripotent cells, an unlimited and quality-controllable source, for therapeutic applications. Stem Cells. 2018..
Human ESC-Derived MSCs Outperform Bone Marrow MSCs in the Treatment of an EAE Model of Multiple Sclerosis. Stem Cell Reports. 2021;16(2):370-371.
Alternative splicing in mesenchymal stem cell differentiation. Stem Cells. 2020..